MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Pesticide Exposure in PD with and without Genetic Risk Variants

    E. Brown, C. Meng, S. Goldman, C. Tanner (San Francisco, CA, USA)

    Objective: To evaluate the association between pesticide exposure and development of Parkinson’s disease (PD) in idiopathic and genetic PD, and to determine whether clinical features…
  • MDS Virtual Congress 2020

    Association Between Diet & Parkinson’s Disease Progression

    L. Mischley, J. Farahnik (Kenmore, WA, USA)

    Objective: The objective of this study was to evaluate whether food choices are associated with patient-reported Parkinson's disease (PD) severity over time. Background: Several traditional…
  • MDS Virtual Congress 2020

    Clinical and imagiological features in Portuguese patients with SPG7 mutations

    I. Antunes Cunha, J. Afonso Ribeiro, A. Morgadinho, J. Lemos, C. Januário (Coimbra, Portugal)

    Objective: To better characterize spastic paraplegia type 7 (SPG7) phenotype in a Portuguese cohort of patients. Background: Hereditary spastic paraplegias(HSP) and cerebellar ataxias(CA) are heterogeneous…
  • MDS Virtual Congress 2020

    Huntington’s Disease in Israel – 20 years of follow up from Maccabi Healthcare Services

    Y. Barer, N. Gavrielov, P. Coloma, M. Martinec, I. Korolev, I. Goldshtein (Tel Aviv, Israel)

    Objective: To describe Huntington’s Disease (HD) epidemiology in Israel and depict comorbidities and longitudinal healthcare resources utilization. Background: HD is a rare, inherited neurodegenerative disorder,…
  • MDS Virtual Congress 2020

    Cardiovascular risk factors in a pre-manifest and manifest population of Huntington’s disease

    E. Gatto, N. Gonzalez Rojas, M. Cesarini, J. Etcheverry, G. Da Prat (Buenos Aires, Argentina)

    Objective: To identify cardiovascular risk factors in a self-reported series of local Huntington's disease participants in the ENROLL-HD registry Background: Population studies have contributed to…
  • MDS Virtual Congress 2020

    Remote and frequent assessment of Huntington’s disease in clinical trials: Strategies for assessing and accounting for the practice effect

    A. Wolfer, F. Lipsmeier, R. Tortelli, F.B Rodrigues, L.M Byrne, C. Simillion, T. Kilchenmann, A. Bamdadian, S.A Schobel, E.J Wild, M. Lindemann (Basel, Switzerland)

    Objective: To assess the impact of task repetition on performance in digital assessments on Huntington’s disease (HD) and establish the number of practice test iterations…
  • MDS Virtual Congress 2020

    Higher grey matter aging in multiple system atrophy than Parkinson’s disease

    M.C Kuo, C.L Chen, C.H Tai, W.Y Tseng, R.M Wu (Taipei, Taiwan)

    Objective: To investigate the “brain age” signature in multiple system atrophy (MSA) and Parkinson's disease (PD), and its correlation with motor and cognitive performance. Background:…
  • MDS Virtual Congress 2020

    Neuroprotective effects of allicin microemulsion against intrastriatal rotenone and manganese induced Parkinsonism in rats

    S. Singh (Moga, India)

    Objective: Allicin is flavonoid that possess neuroprotective potential but main impediment is its low bioavailability which was improved with microemulsion. The present study was framed…
  • MDS Virtual Congress 2020

    Paroxysmal Kinesigenic Dyskinesia: Case series from Çukurova University, Turkey

    M. Demirkiran, M. Balal, A. Bisgin, S. Bozdogan (Adana, Turkey)

    Objective: To present the demographic, clinical and genetic data of ten patients with paroxysmal kinesigenic dyskinesia (PKD). Background: PKD is a rare movement disorder triggered…
  • MDS Virtual Congress 2020

    Stiff person syndrome and acethylcoline receptors ganglionic neuronal antibodies

    J. Lester, J. Cojab, E. Klériga (Huixquilucan, Mexico)

    Objective: Describe a case of stiff person syndrome and positivity for acetylcholine receptors ganglionic neuronal antibodies, not reportes before in stiff person syndrome. Background: Acetylcholine…
  • « Previous Page
  • 1
  • …
  • 124
  • 125
  • 126
  • 127
  • 128
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley